Marketing-authorisation holder Β· Canada
Mint Pharmaceuticals Inc
319 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1β25 of 319
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| MINT-ABACAVIR300 mg Β· Tablet | Abacavir | Canada | Marketed | 2019 |
| MINT-ABACAVIR/LAMIVUDINE600 mg + 300 mg Β· Tablet | Abacavir, Lamivudine | Canada | Authorised | |
| MINT-ABIRATERONE250 mg Β· Tablet | Abiraterone | Canada | Authorised | |
| MINT-ABIRATERONE500 mg Β· Tablet | Abiraterone | Canada | Authorised | |
| MINT-ACITRETIN10 mg Β· Capsule | Acitretin | Canada | Marketed | 2018 |
| MINT-ACITRETIN25 mg Β· Capsule | Acitretin | Canada | Marketed | 2018 |
| MINT-ACYCLOVIR200 mg Β· Tablet | Aciclovir | Canada | Marketed | 2022 |
| MINT-ACYCLOVIR800 mg Β· Tablet | Aciclovir | Canada | Marketed | 2022 |
| MINT-ACYCLOVIR400 mg Β· Tablet | Aciclovir | Canada | Marketed | 2022 |
| MINT-ACYCLOVIR OINTMENT5 % / w/w Β· Ointment | Aciclovir | Canada | Authorised | |
| MINT-ALENDRONATE5.0 mg Β· Tablet | Alendronic acid | Canada | Authorised | |
| MINT-ALENDRONATE70.0 mg Β· Tablet | Alendronic acid | Canada | Not marketed | 2012 |
| MINT-AMLODIPINE10 mg Β· Tablet | Amlodipine | Canada | Marketed | 2011 |
| MINT-AMLODIPINE5 mg Β· Tablet | Amlodipine | Canada | Marketed | 2011 |
| MINT-AMOXI/CLAV500 mg + 125 mg Β· Tablet | Amoxicillin, Clavulanic acid | Canada | Authorised | |
| MINT-AMOXI/CLAV875 mg + 125 mg Β· Tablet | Amoxicillin, Clavulanic acid | Canada | Authorised | |
| MINT-AMOXI/CLAV250 mg + 125 mg Β· Tablet | Amoxicillin, Clavulanic acid | Canada | Authorised | |
| MINT-ANASTROZOLE1 mg Β· Tablet | Anastrozole | Canada | Marketed | 2012 |
| MINT-APIXABAN5 mg Β· Tablet | Apixaban | Canada | Marketed | 2022 |
| MINT-APIXABAN2.5 mg Β· Tablet | Apixaban | Canada | Marketed | 2023 |
| MINT-APREMILAST30 mg Β· Tablet | Apremilast | Canada | Not marketed | 2023 |
| MINT-ARIPIPRAZOLE20 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2020 |
| MINT-ARIPIPRAZOLE30 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2020 |
| MINT-ARIPIPRAZOLE5 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2020 |
| MINT-ARIPIPRAZOLE10 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2020 |



